Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
PET imaging of pathological tau correlates more closely with Alzheimer’s disease–related cognitive impairment than does imaging of β-amyloid.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These previous studies suggest that CSF tau biomarkers and Tau PET reflect different aspects of tau pathology and may become abnormal at different stages of the disease.”
From Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive tau PET in Alzheimer's disease (2020) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Elevated tau PET binding in both medial temporal lobe structures and the neocortex is strongly associated with positive amyloid PET scans and with clinical impairment across the normal aging to dementia clinical spectrum [82,130–141].”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [82]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the limited data currently available, tau PET ligand binding is linearly correlated with elevated CSF P-tau [82,83,115]; however, the correlation is imperfect.”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [82]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“we examined the influence of sex to modify the well-characterized cross-sectional association between regional tau PET and global Aβ PET.14–16”
From Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults (2019) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“supports recent evidence that tau may play an early pathological role in Alzheimer’s disease129–131”
From Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) · cites this paper as [131]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression shrinkage and selection via the lasso
Tibshirani, R. (1996) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1996.tb02080.x · Cited by 51,482 · cited 2×
“The family of penalized regression fit here is the elastic net penalty (27): the L1 penalty component enforces sparsity (that is, many bs will be identically 0, not included in the model) (26), whereas the L2 penalty allows highly correlated variables to enter the model simultaneously (27).”
Regularization and Variable Selection Via the Elastic Net
Zou, H., & Hastie, T. (2005) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.1467-9868.2005.00503.x · Cited by 20,957
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Self-citationNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 3×
“The specificity of this relationship strengthens the argument that the identified relationships are disease-specific: elevated tau in the CSF is associated with tau deposition within regions known to be sensitive to AD-related tauopathy (2).”
InfluentialThe Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citationAlzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155 · cited 2×
“Overlap with respect to CDR status likely represents the variable relationship between pathological burden and cognitive symptoms often attributed to differences in host factors, for example, cognitive reserve (8, 23).”
Self-citationOverdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,732
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496 · cited 2×
“The Aβ imaging literature has grown over the past decade (4), whereas tau imaging is a relatively new addition to the field.”
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Research works printed but not linked: 1
- 50. Roussas GG A First Course in Mathematical Statistics Addison-Wesley Pub. Co. Reading, MA 1973
Cited by
Items 701–736 of 736
Short-Lived EEG Synchrony Patterns for Alzheimer’s Disease DiagnosisPreprint
Olcay, B. O. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.23.713571
“Early pathological changes arise in memory-and olfaction-related brain regions [2, 3].”
Xia, Y., Johnson, K. A., Fakhri, G. E., Guehl, N. J., van de Giessen, E., Coomans, E. M., Pijnenburg, Y. A. L., Ossenkoppele, R., & Groot, C. (2026) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-026-07868-5
“While Aβ deposition marks the onset of pathologi - cal changes, tau burden and regional distribution are more closely associated with clinical symptoms and cognitive decline [1, 2, 3].”
Xu, Y. (2016) · theses.fr (ABES) · doi:10.70675/39ceb0d5zfd48z4e4fz84f0z597eb08381d7 · Cited by 1
Andriuta, D. (2019) · theses.fr (ABES) · doi:10.70675/9bc67e49z5496z4d82z8bf5zff9f44d856c0
Development of copper ligands for therepeutic applications
Balderrama-Martínez-Sotomayor, R. (2020) · theses.fr (ABES) · doi:10.70675/449f1d52z9b40z487cza9cczb4edaf3b75f1
Altered neuronal activity in the hippocampal CA3 region in an in vitro model of tauopathy
Goncalves, A. (2020) · theses.fr (ABES) · doi:10.70675/b42db6dez88a0z4a14z93eez8f51d19d46f5
Borcuk, C. (2021) · theses.fr (ABES) · doi:10.70675/c316f2dcz54d3z41cfzb3f5z99c7b2d3cd95 · Cited by 1
Chronic stress and glucocorticoid actions in brain plasticity and Tau pathology
Dioli, C. (2021) · theses.fr (ABES) · doi:10.70675/b812791ezcc0az4036zb746z0d9b5daacfab
Poulot-Becq-Giraudon, Y. (2024) · theses.fr (ABES) · doi:10.70675/0d7a8b92z8393z4d76z82a8z87efe0790346
ADAS-Cog11 performance as a surrogate of tau PET burden in an Asian Alzheimer's disease cohort
Hong, Y.-J., Huang, S.-Y., Hsiao, I., Wu, H.-C., Lin, K., Huang, K., Huang, C.-C., & Hsu, J. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261441801
Ma, X., Mo, X., Li, B., Xu, Y., Long, L., Dong, Q., Ma, Z., Tian, Q., Chen, X., & Qian, J. (2026) · Experimental Brain Research · doi:10.1007/s00221-026-07298-7
“The medial temporal lobe, especially the hippocampus, plays a key role in long-term memory and is a primary locus of AD pathology (Braak and Braak 1998 ; Brier et al. 2016; Ridha et al. 2006 ).”
Vo, T., Gillespie, N. A., Christensen, K., Finkel, D., Kremen, W. S., Nygaard, M., Sachdev, P. S., Thalamuthu, A., & Reynolds, C. A. (2026) · SLEEP · doi:10.1093/sleep/zsag119
“The APOE ε 4 allele has been consistently linked to poorer cognitive performance and accelerated cognitive decline [ 76, 77], affecting both global cognitive function [ 78] and various cognitive domains including memory and executive function [ 79– 83].”
Lei, S., Huang, Z. G., Wang, W., & Meng, Y. (2026) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.70037
BCG vaccination mitigates tau pathology and restores cognitive function in PS19 micePreprint
Shee, S., Huang, M., Baghel, M. S., Zheng, Y., Lun, S., Yadav, S. K., Yadav, N. N., Ruiz-Gonzalez, C. E., Tyagi, S., Nuermberger, E. L., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.12.724591
Neri, L., Anderson, C. A., Fallot, L. B., Mannini, B., & Limbocker, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-99507-8.00045-7
Loss of SMARCAD1 Mitigates Tauopathy
Jadhav, V., Kow, R. L., Beale, A. D., Baum, M., McMillan, P. J., Latimer, C. S., Liachko, N. F., & Kraemer, B. C. (2026) · Aging Cell · doi:10.1111/acel.70543 · Cited by 1
Ishii, K., Yamada, T., Hanaoka, K., Kojita, Y., Kono, A., Kaida, H., Nihashi, T., Sakurai, K., Kato, T., & Nakamura, A. (2026) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-026-07935-x
Fulghum, K., Hayir, A., ANKERIASNIEMI, R., Shaddy‐Gouvion, C., Vang, C. M., Salathe, S. F., Queathem, E. D., Hughey, C. C., Haeri, M., Thyfault, J. P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.03.729999
Huang, H., Xu, K., & Lardelli, M. T. (2026) · Cells · doi:10.3390/cells15121082
Kang, H., Jang, B.-K., Yun, S., Jeong, H., Park, E., Oh, K.-I., Jeong, J., & Jeong, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135748
“This failure to halt cognitive decline has intensified the focus on neurofibrillary tangles, as the anatomical burden of these neurofibrillary tangles correlates much more strongly with neuronal loss and clinical dementia severity than that of A β plaques [6,7].”
Calcium Overloading-Induced UBE2O Upregulation Alleviates Neuronal Apoptosis
Jin, J., Yang, Z., Kang, A., Zhao, Y., Cai, Z., Qiu, M., Song, W., & Wu, Y. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06034-0
Liu, M., Gresham, L. K., Puccetti, N. A., Betthauser, T. J., Johnson, S. C., & Schaefer, S. M. (2026) · Affective Science · doi:10.1007/s42761-026-00394-5
“Tau levels in the temporal lobe, which contains the entorhinal cortex, have previously been shown to track dementia more closely and more strongly predict cognitive impairment than amyloid-β deposition (Brier et al., 2016).”
Optimizing Structural MRI for Alzheimer's Diagnosis: A Preprocessing Approach Using FSL
Maqbali, M. A., Fuliti, M. N. S. A., Qasmi, Z. A., Viswan, V., Shaffi, N., & Mahmud, M. (2025) · IEEE/WIC/ACM International Conference on Web Intelligence and Intelligent Agent Technology (WI-IAT) · doi:10.1109/wi-iat67162.2025.00023
“It is a prominent tool for identifying significant indicators of AD and reliably following its progression [13].”
Genetic and molecular evidence linking CTSH to Alzheimer's disease pathophysiology
Picard, C., Aumont‐Rodrigue, G., Sarty, I. M., Loncke, J., Savard, M., Bruneau, L. M., & Poirier, J. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71833
Bunnell, E., Saltonstall, E., Shanava, E., O’Niel, A., Pederson, A., Marla, S., Llamas, M. L. S., Garg, I., Chaudhari, M., Vodapally, S., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1899626
Alsulami, A., Bogdani, M., MacLean, E. L., Keene, C. D., McGrath, S., Akey, J. M., Benton, B., Borenstein, E., Castelhano, M. G., Coleman, A. E., et al. (2026) · npj Dementia · doi:10.1038/s44400-026-00141-4
“In contrast, studies in AD have demonstrated strong associations between tau pathology and cognitive decline 43,44 .”
Frommann, I., Vogel, S., Jansén, L., Meiberth, D. U., Schild, A., Jessen, F., Zank, S., Schneider, A., McCormick, C., & Wagner, M. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261490478
Páez, A., Piñol‐Ripoll, G., Dakterzada, F., & Dang-Vu, T. T. (2026) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-026-01528-9
“In turn, the accumulation of Aβ and tau in cortical, hypothalamic, and brainstem regions involved in sleep–wake regulation may further disrupt sleep and impair NREM physiology [ 23, 28, 52].”
Rao, Y., Liu, L., Ostaszewski, B. L., Anderson, A. K., Pinilla, V., Shirzadi, Z., Laho, E. M., Stern, A. M., Yau, W. W., Yang, H., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000218564
Self-citationBCG vaccination mitigates tau pathology and restores cognitive function in PS19 mice
Shee, S., Huang, M., Baghel, M. S., Zheng, Y., Lun, S., Yadav, S. K., Yadav, N. N., Ruiz-Gonzalez, C. E., Tyagi, S. K., Nuermberger, E. L., et al. (2026) · Science Advances · doi:10.1126/sciadv.aej4603
Tau extent is associated with lower cognition in Down syndrome‐related Alzheimer's disease
Zammit, M. D., Hartley, S. L., Christian, B. T., & Rafii, M. S. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71925 · Cited by 1
PET for Evaluation of Neurologic Diseases
Veziroglu, E., Nikpanah, M., Farhadi, F., Kalbi, D., Hensley, C., & McConathy, J. (2026) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2026.07.008
The relation of whole-brain functional connectivity to global amyloid and local tau presence
Ziadlou, D., Wales, R., Chen, X., & Leung, H.-C. (2026) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2026.10.007
Metadata
- Authors
- Brier, M. R., Gordon, B., Friedrichsen, K., McCarthy, J., Stern, A., Christensen, J., Owen, C., Aldea, P., Su, Y., Hassenstab, J., Cairns, N. J., Holtzman, D. M., Fagan, A. M., Morris, J. C., Benzinger, T. L. S., & Ances, B. M.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Benzinger, Tammie L. S.
- Ances, Beau M.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2016-05-11
- Volume
- 8
- Issue
- 338
- Pages
- 338ra66-338ra66
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC5267531
- OpenAlex
- W2353776455
- Cited by
- 734
- References
- 56
- Citations by year
- 2026: 40 · 2025: 60 · 2024: 58 · 2023: 69 · 2022: 64 · 2021: 90 · 2020: 101 · 2019: 80 · 2018: 73 · 2017: 75 · 2016: 23
- FWCI
- 74.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion, cc-by)
- PubMed Central (acceptedVersion, cc-by)
- Open Scholarship Institutional Repository (Washington University in St. Louis) (submittedVersion)
- Funders
- NIH (P50AG05681, P01AG003991, P01AG026276, 5P30NS048056, 2UL1TR000448, 5RO1AG04343404)
- NSF (DMS1300280)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- Alzheimer's disease, tau PET imaging, cerebrospinal fluid tau, temporal lobe, preclinical Alzheimer's disease, cognitive performance, disease progression, neurofibrillary tangles, neuritic plaques
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Brain, Cognition, Female, Humans, Male, Peptide Fragments, Amyloid beta-Peptides, tau Proteins, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.